Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zeotone
- Development stage
- Unknown
- Lead developer
- AVN Ayurveda Formulations
- Administration
- Oral
01
Overview
Zeotone is a proprietary Ayurvedic herbal formulation developed by AVN Ayurveda Formulations for the management of osteoarthritis and joint health. Available in tablet and soft gel capsule forms, it is designed as an anti-degenerative medicine that aims to reduce and reverse the degeneration of articular cartilages. The formulation follows the Ayurvedic principle of 'Abhyantara Snehapaana' (internal oleation) to treat Vataja and Asthi-majja gata vikaras (bone and marrow disorders). The soft gel variant specifically contains a proprietary oil prepared by processing sesame oil (Tila Taila) with a blend of traditional herbs, including dasamoola, baladvaya, yashtimadhu, and punarnava, along with Gandha tailam. It is marketed to AYUSH practitioners in India as a treatment for degenerative joint conditions.
- Brand names
- Zeotone
- Other names
- Zeotone soft gel capsulesZeotone tablets
02
Targets
STAT3 (Signal Transducer and Activator of Transcription 3)IL-6 (Interleukin 6)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)NF-κBALOX12 (Arachidonate 12-lipoxygenase, 12S type)MMP12 (Macrophage Metalloelastase)TNFA (Tumor necrosis factor alpha (soluble))PGHS-1 (Prostaglandin G/H Synthase 1)IL1B (Interleukin-1 beta)
Beyond the preview
Go deeper on Zeotone.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Zeotone.